查找临床试验
已按「视神经脊髓炎」检索，对应国际通用词 neuromyelitis optica
共找到 26 项正在招募的试验（在中国／港澳台设有中心）
数据更新于 00:19，每 5 分钟自动同步Clinical Study of B001 Injection in Subjects With Neuromyelitis Optic Spectrum Disorder (NMOSD)
China
年龄 18 Years – 不限
Shanghai Pharmaceuticals Holding Co., Ltd
A Clinical Study of B001 Injection in the Treatment of Neuromyelitis Optica Spectrum Disorders(NMOSD)
China
年龄 18 Years – 不限
Shanghai Jiaolian Drug Research and Development Co., Ltd
Therapy in the Acute Phase of NMOSD: A Multicenter Prospective Real-World Study
China
年龄 18 Years – 65 Years
Chinese PLA General Hospital
Ofatumumab in AQP4-IgG Seropositive NMOSD
China
年龄 18 Years – 不限
Tang-Du Hospital
Clinical and Imaging Cohort of Neuroinflammation Diseases in China (CLUE)
China
年龄 16 Years – 75 Years
Beijing Tiantan Hospital
HANDLE-a Real World Study on Satralizumab in NMOSD
China
年龄 12 Years – 不限
Huashan Hospital
Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity Study of Ravulizumab in Chinese Adults With Neuromyelitis Optica Spectrum Disorder (NMOSD)
China
年龄 18 Years – 130 Years
Alexion Pharmaceuticals, Inc.
A Multicenter Prospective Real-World Effectiveness and Safety of Satralizumab in the Early Treatment of Attacks in NMOSD
China
年龄 18 Years – 不限
Junwei Hao, MD
Registry of Patients With AQP4+ NMOSD Treated With Alexion C5 Inhibitor Therapies
United States、Argentina、Canada、China、Germany 等 8 国
年龄 18 Years – 不限
Alexion Pharmaceuticals, Inc.
Biomarkers in Autoimmune Disease of Nervous System
China
年龄 18 Years – 不限
Tongji Hospital
Cohort Study on Neuroimmune Diseases in the Reproductive Age
China
年龄 20 Years – 55 Years
Third Affiliated Hospital, Sun Yat-Sen University
Modified Zipper Therapy for AQP4-IgG Positive Neuromyelitis Optica Spectrum Disorder
China
年龄 18 Years – 80 Years
Tianjin Medical University General Hospital